• Hausa Edition
  • Podcast
  • Conferences
  • LeVogue Magazine
  • Business News
  • Print Advert Rates
  • Online Advert Rates
  • Contact Us
Tuesday, July 29, 2025
Leadership Newspapers
Read in Hausa
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
Leadership Newspapers
No Result
View All Result

US Agency Approves Cure For Sickle Cell Disease

by Leadership News and Pamela Ephraim
2 years ago
in Health
US
Share on WhatsAppShare on FacebookShare on XTelegram

The United States Food and Drug Administration (FDA) has approved a treatment for sickle cell disease.

Advertisement

The therapy, called Casgevy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is the first medicine to be approved in the United States that uses the gene-editing tool CRISPR, which won its inventors the Nobel Prize in Chemistry in 2020.

The approval marks the first of two potential breakthroughs for the inherited blood disorder.

The FDA on Friday also approved a second treatment for sickle cell disease, called Lyfgenia, a gene therapy from drugmaker Bluebird Bio. Both treatments work by genetically modifying a patient’s own stem cells.

Until now, the only known cure for sickle cell disease was a bone marrow transplant from a donor, which carries the risk of rejection by the immune system, in addition to the difficult process of finding a matching donor.

RELATED

FG To Boost Milk Production

FG To Boost Milk Production

4 hours ago
Japa: Medical Schools’ Bid To Double Students’ Intake Under Threat

Nurses, Midwives To Begin 7-Day Warning Strike Tuesday

11 hours ago

Casgevy, which was approved for people ages 12 and older, removes the need for a donor. Using CRISPR, it edits the DNA found in a patient’s stem cells to remove the gene that causes the disease.

According to NBC News, the new therapy costs $2.2 million per patient.


We’ve got the edge. Get real-time reports, breaking scoops, and exclusive angles delivered straight to your phone. Don’t settle for stale news. Join LEADERSHIP NEWS on WhatsApp for 24/7 updates →

Join Our WhatsApp Channel




SendShareTweetShare
Previous Post

PICTORIAL: VP Shettima Delivers Al-Hikmah Varsity’s 13th Convocation Lecture In Kwara

Next Post

Akwaba: Yemi Alade Relishes Contribution To 2024 AFCON Official Theme Song

Leadership News and Pamela Ephraim

Leadership News and Pamela Ephraim

You May Like

FG To Boost Milk Production
Health

FG To Boost Milk Production

2025/07/29
Japa: Medical Schools’ Bid To Double Students’ Intake Under Threat
Health

Nurses, Midwives To Begin 7-Day Warning Strike Tuesday

2025/07/28
Insecurity Threatens FCT Doctors’ Response To Emergencies —NMA
Health

NMA Gives Federal Gov’t 21-Day Ultimatum Over Unmet Demands

2025/07/28
FG Working Towards Zero-malaria Target – Minister
Health

Nigeria Loses ₦17.9trn Yearly To Hepatitis — Minister

2025/07/28
Dry Mouth, Big Problem: What Your Mouth Is Trying To Tell You
Health

Dry Mouth, Big Problem: What Your Mouth Is Trying To Tell You

2025/07/27
Your Gut’s Best Friend: A Salad That Paints A Healthier Picture
Health

Your Gut’s Best Friend: A Salad That Paints A Healthier Picture

2025/07/27
Leadership Conference advertisement

LATEST

Air Peace Hosts Leadership, Customers’ Retreat For Management Team

FAAN Signs Capacity Building MoU With Dubai-based Firm

NHIA To Reaccredit Hospitals Over Poor Healthcare Services To Policyholders

SanlamAllianz To Spark Creativity, Financial Confidence Among Teens

Digital Channels Push Heirs Insurance Group’s Revenue Up By 200%

Universal Insurance Evolves Enhanced Third Party Motor Policy

Ibom Air Expands Operations, Begins Daily Flights To Enugu, Calabar

Lassa Fever: NCDC Confirms 11 New Cases In 3 States

Stop Selling Personal Information, NIN, NIMC Warns Nigerians

SEC Disowns Purported AGM Of Tourist Company, Reaffirms Regulatory Oversight

© 2025 Leadership Media Group - All Rights Reserved.

No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us

© 2025 Leadership Media Group - All Rights Reserved.